Mycobacterium houstonense Schinsky et al. (ATCC® 49403)

Strain Designations: Mf 89 [DSM 44676, W5198]  /  Type Strain: yes  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Deposited As Mycobacterium fortuitum da Costa Cruz
Strain Designations Mf 89 [DSM 44676, W5198]
Isolation
Tissue, human, Houston Texas, United States, January, 1980
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain yes RefSchinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
Comments
Biovariant 3
Medium ATCC® Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor RJ Wallace
Isolation
Tissue, human, Houston Texas, United States, January, 1980
References

Wallace RJ J, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163: 598-603, 1991. PubMed: 1995732

Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725

face wound

Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725

Cross References

Nucleotide (GenBank) : X65528 M.fortuitum 16S rRNA (ATCC 49403).

Nucleotide (GenBank) : AY012579 Mycobacterium houstonense 16S ribosomal RNA gene, partial sequence.

Nucleotide (GenBank) : U86085 Mycobacterium fortuitum superoxide dismutase (SOD) gene, partial cds.

Nucleotide (GenBank) : S74032 tetK=tetracycline resistant [Mycobacterium fortuitum, ATCC 49403, Genomic Mutant, 308 nt].

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation